Prostate News and Research

RSS

Study compiles the most comprehensive list of genetic variants associated with prostate cancer risk

A globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk -; 451 in all -; through a whole-genome analysis that ranks as the largest and most diverse investigation into prostate cancer genetics yet.

9 Nov 2023

Study finds 4% of Icelanders to carry an actionable genotype associated with shortened lifespan

Scientists at deCODE genetics, a subsidiary of Amgen, have published a study on actionable genotypes detected in the Icelandic population and their association with lifespan.

8 Nov 2023

AI-powered radiation therapy revolutionizes cancer treatment at Henry Ford West Bloomfield Hospital

Patients undergoing radiation therapy for certain types of cancer at Henry Ford West Bloomfield Hospital are among the first in the country with access to a cutting-edge treatment system that increases accuracy and precision, enhances patient comfort, and minimizes side effects.

8 Nov 2023

Study shows linear associations between body mass index and site-specific tumors in young males

The associations between body mass index (BMI) among young males and new-onset site-specific tumors.

8 Nov 2023

UTHSC's drug candidate for advanced prostate cancer goes to first clinical trial

A drug candidate developed by researchers at the University of Tennessee Health Science Center for advanced metastatic castration-resistant prostate cancer is now in its first clinical trial.

6 Nov 2023

High BMI in late teens linked to higher risk of 17 different cancers later in life

Men who are overweight or obese at age 18 have a higher risk of 17 different cancers later in life. This has been shown in a study at the University of Gothenburg.

6 Nov 2023

Black men may face an increased risk of prostate cancer than white men at lower PSA levels

Black men in the United States are more likely to develop prostate cancer than white men, and after diagnosis, they're more likely to have advanced disease and to die than white men with the disease.

6 Nov 2023

Cancer neuroscience: A new frontier in cancer treatment

Cancer cells hijack normal biological processes, allowing them to multiply. For example, tumors spur construction of new blood vessels, building themselves "highways" to supply nutrients.

1 Nov 2023

Docetaxel improves survival in men with high-grade prostate cancer and low PSA

Men with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis.

1 Nov 2023

Highly sensitive blood test shows promise for early detection of common deadly cancers

Most cancers become deadly by keeping a low profile, causing no symptoms until they're too advanced to treat. Ovarian and gastroesophageal cancers are among the most notorious for this sly disease progression, often leading to late-stage diagnoses.

1 Nov 2023

Study unveils new approach to more precise, long-lasting, and less toxic cancer treatment

For too long, cancer treatment has been a double-edged sword – the very treatments designed to kill cancer cells often wrought havoc on healthy ones too.

30 Oct 2023

Study offers the most comprehensive look to date on prostate cancer disparities

Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality healthcare is equal, regardless of socioeconomic status.

27 Oct 2023

Study finds link between industry payments to oncologists and non-recommended cancer treatments

Patients with cancer whose oncologist receives payments from industry appear more likely to receive some non-recommended and low value treatments, finds a US study published by The BMJ today.

25 Oct 2023

Study finds racial disparities in receipt of low value health care

Older Black Americans are more likely to receive low value acute diagnostic tests than older White Americans, while older White Americans were more likely to receive low value screening tests and treatments, finds a study published by The BMJ today.

25 Oct 2023

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

The therapeutic potential of resveratrol, a red grape polyphenol.

25 Oct 2023

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinoma

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibitors and anti-angiogenic therapies compared with everolimus in a phase 3 clinical trial.

24 Oct 2023

Prostate News and Research

Study compiles the most comprehensive list of genetic variants associated with prostate cancer risk

Study finds 4% of Icelanders to carry an actionable genotype associated with shortened lifespan

AI-powered radiation therapy revolutionizes cancer treatment at Henry Ford West Bloomfield Hospital

Study shows linear associations between body mass index and site-specific tumors in young males

UTHSC's drug candidate for advanced prostate cancer goes to first clinical trial

High BMI in late teens linked to higher risk of 17 different cancers later in life

Black men may face an increased risk of prostate cancer than white men at lower PSA levels

Cancer neuroscience: A new frontier in cancer treatment

Docetaxel improves survival in men with high-grade prostate cancer and low PSA

Highly sensitive blood test shows promise for early detection of common deadly cancers

Study unveils new approach to more precise, long-lasting, and less toxic cancer treatment

Study offers the most comprehensive look to date on prostate cancer disparities

Study finds link between industry payments to oncologists and non-recommended cancer treatments

Study finds racial disparities in receipt of low value health care

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinoma

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

Can selenium and vitamin E supplementation prevent recurrence and progression of non–muscle-invasive bladder cancer?

Scientists identify two promising new treatment options for men with recurrent prostate cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News